Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals

@article{Kristensen2022PhenotypicAF,
  title={Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals},
  author={Anne B. Kristensen and Kathleen M. Wragg and Hillary A. Vanderven and Wen Shi Lee and Julie Silvers and Helen E. Kent and Michael D. Grant and Anthony D. Kelleher and Jennifer A. Juno and Stephen J. Kent and Matthew S. Parsons},
  journal={Clinical and Experimental Immunology},
  year={2022},
  volume={210},
  pages={163 - 174},
  url={https://api.semanticscholar.org/CorpusID:252010117}
}
The abundance of highly functional CD57+NKG2C+ NK cells in HIV-1-infected individuals raises the possibility that these NK cells could play a role inAIDS pathogenesis or serve as effector cells for therapeutic/cure strategies.
View on PubMed
academic.oup.com
2 Citations
Background Citations
1

Figures and Tables from this paper

2 Citations

γδ T cells mediate robust anti‐HIV functions during antiretroviral therapy regardless of immune checkpoint expression

Although antiretroviral therapy efficiently suppresses HIV viral load, immune dysregulation and dysfunction persist in people living with HIV (PLWH), the extent to which they are reconstituted upon ART is currently unclear.

Exploring HIV Vaccine Progress in the Pre-Clinical and Clinical Setting: From History to Future Prospects

This review delves into the history of HIV vaccines and the current efforts in HIV prevention, emphasizing pre-clinical vaccine development using the non-human primate model of HIV infection, which offers valuable insights into potential preventive strategies for combating HIV.

47 References

Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection

The identification of selective NK subsets with retained effector activity in HIV-1-infected subjects raises the possibility of developing therapeutic strategies that exploit specific NK subpopulations to achieve better HIV- 1 control.

Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

The preferential expansion of a unique subset of NK cells coexpressing the activating CD94–NKG2C receptor and CD57 in CMV+ donors is demonstrated and it is proposed that CD57 might provide a marker of “memory” NK cells that have been expanded in response to infection.

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

It is suggested that the expansion of this highly dysfunctional CD56(-)/CD16(+) (CD56(-)) NK cell subset in HIV-viremic individuals largely accounts for the impaired function of the total NK cell population.

Human Cytomegalovirus-Induced NKG2Chi CD57hi Natural Killer Cells Are Effectors Dependent on Humoral Antiviral Immunity

It is demonstrated that NKG2Chi CD57hi NK cells are intrinsically responsive to signaling through CD16 cross-linking, and the activity of pathogen-induced innate immune cells can be enhanced by adaptive humoral immunity.

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

A combination of a mature phenotype, a higher cytotoxic capacity, aHigher sensitivity to stimulation via CD16, with a decreased responsiveness to cytokines, and a decreased capacity to proliferate suggest that CD57(+) NK cells are highly mature and might be terminally differentiated.

NKG2C+CD57+ Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8+ T Cell Evolution towards Senescence

Stronger NK and adaptive immune responses against HCMV and an inverse correlation between NKG2C+CD57+ NK expansion and proliferative reserve of H CMV-specific CD8+ T cells, as signified by CD28 expression, indicate parallel evolution of NK and T cell responses againstHCMV in HIV infection.

Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection

The inversion of NKG2A/NKG2C ratio characterizes advanced stages of HIV-1 disease in patients showing a concomitant HCMV infection and renders this cohort of patients distinguishable from LTNPs and early HIV- 1- infected individuals.

NKG2C+ memory-like NK cells contribute to the control of HIV viremia during primary infection: Optiprim-ANRS 147

Memory‐like NK cells were already present at the time of HIV infection and constituted a preexisting immune response able to contribute to natural control of HIV, and appears to be a good candidate in the search of predictive markers to monitor HIV remission.

Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates

An expansion of the functionally defective CD56-/CD16+ population of NK cells in viremic versus aviremic patients is demonstrated and functional tests confirmed that the abnormal expression of the activating receptors and of iNKRs was associated with a markedly impaired NK cytolytic function.

Adaptive NKG2C+CD57+ Natural Killer Cell and Tim-3 Expression During Viral Infections

It is shown that persistent immune activation during chronic viral co-infections interferes with the functional phenotype of NK cells by modulating the Tim-3 pathway; a decrease inTim-3 expression combined with the acquisition of inhibitory receptors skewed NK cells toward an exhausted and cytotoxic phenotype in an inflammatory environment during chronic HIV infection.
...

Related Papers

Showing 1 through 3 of 0 Related Papers